Editorial: 21st International Conference on Bioinformatics (InCoB 2022)—accelerating innovation to meet biological challenges: the role of bioinformatics

Asif M. Khan, Harpreet Singh, Shoba Ranganathan, Takashi Gojobori, Xin GaoFrontiers in Genetics 2024 · DOI · OpenAlex

Abstract

The 21st International Conference on Bioinformatics (InCoB 2022) served as a pivotal platform for discussing the evolving role of bioinformatics in addressing global biological "grand challenges." This editorial synthesizes key research presented at the conference, ranging from machine learning applications in antimicrobial resistance to novel algorithms for long-read sequencing. By moving beyond narrow data analysis toward a holistic, interdisciplinary approach, the field aims to bridge the gap between complex genomic data and actionable insights in healthcare and environmental science.

Introduction

Modern biology is increasingly defined by its "grand challenges"—complex problems such as mapping plant and microbial metabolism or linking genotypes to phenotypes across diverse ecosystems. While bioinformatics was originally conceived as the study of informatic processes in biotic systems, recent trends have often narrowed its scope to specific data analysis tasks. The 21st International Conference on Bioinformatics (InCoB 2022) sought to realign the field with its broader mission: driving innovation through interdisciplinary collaboration and the development of robust computational frameworks.

Methodological Innovations

The research highlighted in InCoB 2022 demonstrates a diverse array of methodologies designed to extract meaning from "noisy" biological data:

  • Pan-genomic Machine Learning: Researchers utilized machine learning models trained on the Salmonella enterica pan-genome to predict Minimum Inhibitory Concentrations (MIC) for antibiotics. This approach identifies novel markers beyond known resistance genes.
  • Transcriptomic Integration: By combining traditional medicinal knowledge with modern transcriptomic analysis, studies identified immune-related gene expressions and potential drug targets for gastric cancer.
  • Prognostic Modeling in Oncology: mRNA expression models were developed based on microtubule-associated gene families to predict patient outcomes in Diffuse Large B-cell Lymphoma (DLBCL).
  • Structural DNA Analysis: Investigations into the physical properties of DNA binding sites for 21 transcription factors in M. tuberculosis provided insights into pathogen regulation.
  • Long-read Error Correction (LCAT): A new algorithm, LCAT (a wrapper for the MECAT method), was introduced to improve the accuracy of third-generation transcriptome sequencing while preserving essential isoform diversity.

Key Insights and Results

The conference showcased several breakthroughs that underscore the power of integrated bioinformatics:

  • Beyond Known Markers: Pan-genomic analysis proved more effective than targeted gene sets for identifying novel antibiotic resistance mechanisms.
  • Bridging Ancient and Modern Medicine: The validation of 12 herbal medicines and 27 ingredients identified TLR4 and KRAS as essential targets for modulating the tumor microenvironment in gastric cancer.
  • Pathogen Roadmap: Mapping transcription factor binding sites in M. tuberculosis offers a new roadmap for understanding pathogenicity and drug resistance.
  • Algorithmic Efficiency: The LCAT algorithm significantly refined the accuracy of long-read sequencing data, a critical step for high-resolution genomic studies.

Discussion and Future Directions

Despite these advancements, significant hurdles remain. The "technical language barrier" between computational and biological researchers continues to impede progress, highlighting a need for revamped bioinformatics education. Furthermore, the integration of massive omics datasets with biochemical and biophysical measurements remains an unfulfilled challenge.

The editorial also notes the importance of resilient scientific communities. Disruptions such as the COVID-19 pandemic and the loss of influential figures like Dr. Vladimir Bajic emphasize the need for global connectivity through organizations like APBioNET to maintain research momentum.

Conclusion

InCoB 2022 reinforced that bioinformatics is not merely a support tool but a foundational pillar of modern biological research. By embracing holistic methodologies and fostering interdisciplinary dialogue, the field is well-positioned to meet the biological challenges of the 21st century.

Summary updated

Abstract

Editorial: 21st International Conference on Bioinformatics (InCoB 2022)—accelerating innovation to meet biological challenges: the role of bioinformatics <h2>Other Information</h2> Published in: Frontiers in Genetics<br> License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fgene.2024.1365223" target="_blank">https://dx.doi.org/10.3389/fgene.2024.1365223</a>
BibTeX
@inproceedings{khan2024editorial,
  author = {Asif M. Khan and Harpreet Singh and Shoba Ranganathan and Takashi Gojobori and Xin Gao},
  title = {{Editorial: 21st International Conference on Bioinformatics (InCoB 2022)—accelerating innovation to meet biological challenges: the role of bioinformatics}},
  booktitle = {Frontiers in Genetics},
  year = {2024},
  doi = {10.3389/fgene.2024.1365223},
}
Figure